Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Extending new discoveries in the deep subsurface – UFS paper published in Nature Communications
2015-11-30



Scanning electron microscopy of some of the Eukarya recovered from two different mines. (a) Dochmiotrema sp. (Plathyelminthes), (b) A. hemprichi (Annelida), (c) Mylonchulus brachyurus (Nematoda), (d) Amphiascoides (Arthropoda). Scale bar, 50 µm (a,b), 100 µm (c), 20 µm (d).

Following the discovery of the first Eukarya in the deep subsurface (Nature, 2010) by a research group from the Department of Microbial, Biochemical, and Food Biotechnology at the University of the Free State (UFS) and their international collaborators, intense interest has developed in understanding the diversity of more complex organisms living in these extreme environments.

Prof Gaetan Borgonie from Extreme Life Isyensya, together with a group of UFS researchers, took this research further, resulting in a paper on this research released in Nature Communications – impact factor 11.47.  This paper is an extension of the first reports of more complex life at great depths, and their abilities to survive these harsh conditions.

Ten authors from the UFS contributed with the array of expertise needed to define this discovery. The group was supported by staff from the different mining groups, long-term leading collaborators from the USA and Canada, and the idea specialist driver of the paper, Prof Borganie.

“After a sampling campaign that lasted more than two years, we identified that Platyhelminthes, Rotifera, Annelida and Arthropoda are thriving at 1.4 km depths in fissure water up to 12,000-years old in the South African mines of Driefontein and Kopanang,” said Prof Borgonie, who was appointed as associated researcher in the Department of Microbial, Biochemical, and Food Biotechnology.

This paper really opens a “can of worms” so to speak. According to Prof Esta van Heerden from the Department of Microbial, Biochemical and Food Biotechnology at the UFS they extended to define protozoa and fungi. “However, they are present in low numbers,” she said.

Characterisation of the different species reveals that many are opportunistic organisms. In house-adapted video equipment was used to film inside the fissure for the home of the organisms.

This is the first-known study to demonstrate the in situ distribution of biofilms on fissure rock faces using video documentation. Calculations suggest that food, not dissolved oxygen, is the limiting factor for population growth. The discovery of a group of complex multicellular organisms in the underground has important implications for the search for life on other planets in our solar system.

More articles

The strange beasts that live in solid rock deep underground
A microscopic ‘zoo’ is found deep, deep underground

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept